Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
(1-->3)-beta-D-Glucans have a variety of biological and immunopharmacological properties, and they are used clinically as biological response modifiers (BRMs). Clinically, these glucans have often been used for long periods by multiple dosing. During studies on the clearance and metabolism of the glucans in mice, we have found that, in the case of a single dose, the glucan was cleared from blood eventually, and remained constant in the organs for at least one month. Here, we investigated the clearance of glucans from the blood following multiple dosing using MRL lpr/lpr mice with an autoimmune disease. Two kinds of glucans, GRN from Grifola frondosa and SSG from Sclerotinia sclerotiorum, were administered to the mice once a week for more than 35 weeks (250 micrograms/week/mouse by the intraperitoneal route). Examination of the blood clearance of the glucans in these mice revealed that the glucan concentrations were always high (about 20 micrograms/ml for GRN and 200 micrograms/ml for SSG). It is also shown that the glucans were significantly deposited in the liver and spleen of these mice. These findings suggest that administration of a large quantity of the glucan saturated the reticuloendothelial system, resulting in circulation of the glucan in the blood.
Miura
N N
NN
Laboratory for Immunopharmacology of Microbial Products, Tokyo University of Pharmacy and Life Science, Japan.
Ohno
N
N
Aketagawa
J
J
Tamura
H
H
Tanaka
S
S
Yadomae
T
T
D000818:Animals; D005260:Female; D005936:Glucans / Q000097:blood* / Q000493:pharmacokinetics*; D007274:Injections, Intraperitoneal; D008099:Liver / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D051379:Mice; D008813:Mice, Inbred ICR; D008817:Mice, Mutant Strains; D013154:Spleen / Q000378:metabolism; D047071:beta-Glucans
D005936:Glucans; D047071:beta-Glucans; C048444:grifolan; C033363:beta-1,3-glucan